These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 1687848)
1. A clinical scientist's view of preclinical drug testing requirements. Dayan AD Hum Exp Toxicol; 1991 Nov; 10(6):395-7. PubMed ID: 1687848 [No Abstract] [Full Text] [Related]
2. A clinical scientist's view of pre-clinical drug testing requirements. Berryman EL Hum Exp Toxicol; 1993 Jan; 12(1):51-2. PubMed ID: 8094971 [No Abstract] [Full Text] [Related]
3. Safety pharmacology: an essential interface of pharmacology and toxicology in the non-clinical assessment of new pharmaceuticals. Claude JR; Claude N Toxicol Lett; 2004 Jun; 151(1):25-8. PubMed ID: 15177637 [TBL] [Abstract][Full Text] [Related]
5. [The current requirements for the preclinical study of the safety of new drugs]. Arzamastsev EV; Liubimov BI Eksp Klin Farmakol; 1995; 58(3):7-12. PubMed ID: 7663306 [No Abstract] [Full Text] [Related]
6. International Workshop on the Use of Pharmacological Methods in Safety-Evaluation of New Drugs, 1977. Proceedings. Pharmacol Ther B; 1979; 5(1-3):1-605. PubMed ID: 493303 [No Abstract] [Full Text] [Related]
7. [Animal toxicology studies necessary for clinical research and the registry of drugs for human use: conclusions of the International Conference of Harmonization (and II)]. Tristán C; Galende I; Rubio Terrés C; Duque I Med Clin (Barc); 1994 May; 102(20):791-6. PubMed ID: 7913735 [No Abstract] [Full Text] [Related]
10. From cells to QSAR: Alternative predictive models in toxicology. Sambuy Y; Bassi AM; Scanarotti C; Caloni F ALTEX; 2017; 34(1):168-171. PubMed ID: 28105479 [No Abstract] [Full Text] [Related]
11. Non-clinical local tolerance testing of medicinal products. CPMP Working Party on Safety of Medicinal Products. Pharmacol Toxicol; 1991 Mar; 68(3):233-6. PubMed ID: 2057456 [No Abstract] [Full Text] [Related]
12. Preclinical safety testing of new drugs. Keysser CH Ann Clin Lab Sci; 1976; 6(2):197-205. PubMed ID: 814855 [TBL] [Abstract][Full Text] [Related]
13. Guideline limit volumes for dosing animals in the preclinical stage of safety evaluation. Toxicology Subcommittee of the Association of the British Pharmaceutical Industry. Hull RM Hum Exp Toxicol; 1995 Mar; 14(3):305-7. PubMed ID: 7779463 [TBL] [Abstract][Full Text] [Related]
14. Toxicology in the drug discovery and development process. Dorato MA; Buckley LA Curr Protoc Pharmacol; 2006 Apr; Chapter 10():Unit10.3. PubMed ID: 22294168 [TBL] [Abstract][Full Text] [Related]
15. Safety assessment of drug residues. Jackson BA J Am Vet Med Assoc; 1980 May; 176(10 Spec No):1141-4. PubMed ID: 6894293 [TBL] [Abstract][Full Text] [Related]
16. Rationality and regulatory requirements--a view from Britain. Dayan AD Prog Clin Biol Res; 1987; 235():89-106. PubMed ID: 3602003 [No Abstract] [Full Text] [Related]
17. The debate on animal ADME studies in drug development: an update. Pellegatti M Expert Opin Drug Metab Toxicol; 2014 Dec; 10(12):1615-20. PubMed ID: 25373428 [TBL] [Abstract][Full Text] [Related]
18. Metabolic and kinetic aspects of toxicological studies. 19 May 1987, Paris, France. Xenobiotica; 1988 Jan; 18 Suppl 1():1-96. PubMed ID: 3344587 [No Abstract] [Full Text] [Related]
19. Reproductive toxicology guidelines: comparison and application. Beltrame D; Mazué G Ann Ist Super Sanita; 1993; 29(1):3-14. PubMed ID: 8129269 [TBL] [Abstract][Full Text] [Related]
20. [Good preclinical study, as an obligatory stage in design and clinical use of new medicinal preparations]. Vasil'ev AN Antibiot Khimioter; 2012; 57(1-2):41-9. PubMed ID: 22741201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]